Risk factors for cisplatin-induced long-term nephrotoxicity in pediatric cancer survivors

Arga M., Oguz A., PINARLI F. G., KARADENİZ C., Citak E. C., Emeksiz H. C., ...Daha Fazla

PEDIATRICS INTERNATIONAL, cilt.57, sa.3, ss.406-413, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 57 Sayı: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1111/ped.12542
  • Dergi Adı: PEDIATRICS INTERNATIONAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.406-413
  • Gazi Üniversitesi Adresli: Evet

Özet

BackgroundThe aim of this study was to compare the nephrotoxicity risk of cisplatin (CPL) and ifosfamide (IFO) combination treatment (CT) with that of CPL alone and to evaluate the prevalence of CPL-induced long-term nephrotoxicity in pediatric cancer survivors (CS).